NEWMED ENERGY - LIMITED PARTNERSHIP Financials NewMed Energy - Limited Partnership
Equities
NWMD
IL0004750209
Oil & Gas Exploration and Production
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 943.7 ILa | -2.19% |
|
-3.21% | -9.26% |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 12,208 | 11,077 | - |
| Enterprise Value (EV) 1 | 18,185 | 16,296 | 15,121 |
| P/E ratio | - | - | - |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | - | - | - |
| EV / FCF | 11.7 x | 7.77 x | 7.46 x |
| FCF Yield | 8.54% | 12.9% | 13.4% |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 1,173,815 | 1,173,815 | - |
| Reference price 2 | 10.40 | 9.437 | 9.437 |
| Announcement Date | 3/19/24 | - | - |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net sales | - | - | - |
| EBITDA | - | - | - |
| EBIT | - | - | - |
| Operating Margin | - | - | - |
| Earnings before Tax (EBT) | - | - | - |
| Net income | - | - | - |
| Net margin | - | - | - |
| EPS | - | - | - |
| Free Cash Flow 1 | 1,553 | 2,097 | 2,028 |
| FCF margin | - | - | - |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 3/19/24 | - | - |
1ILS in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Debt 1 | 5,977 | 5,219 | 4,044 |
| Net Cash position 1 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow 1 | 1,553 | 2,097 | 2,028 |
| ROE (net income / shareholders' equity) | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - |
| Assets | - | - | - |
| Book Value Per Share | - | - | - |
| Cash Flow per Share | - | - | - |
| Capex | - | - | - |
| Capex / Sales | - | - | - |
| Announcement Date | 3/19/24 | - | - |
1ILS in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
9.437
ILS
Average target price
11.3
ILS
Spread / Average Target
+19.74%
| 1st Jan change | Capi. | |
|---|---|---|
| -9.26% | 2.9B | |
| +37.58% | 523M | |
| +15.94% | 81.24M |
- Stock Market
- Equities
- NWMD Stock
- Financials NewMed Energy - Limited Partnership
